Get the app
US › Healthcare

Turn Therapeutics Inc. Common Stock (TTRX)

US · Healthcare · Biotechnology

$13.82+0.73%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-5.8M
EPS
$-0.07
EPS estimate
$-0.02

EPS came in at -0.07 against a street estimate of -0.02 — a miss of 250.0%.

Key statistics

Market cap
$385.4M
Forward P/E
0.0
P/B
561.92
Book value
$0.02
EPS (TTM)
$-0.28
52-week high
$14.39
52-week low
$2.57
50-day MA
$9.66
200-day MA
$5.52

Analyst view

with an average price target of $26.00.

Shareholding

Insiders
53.88%
Institutions
3.86%

Largest institutional holders

FundStake
Steel Peak Wealth Management LLC0.82%
DDFG Inc0.36%
Wellington Shields & Co., LLC0.22%
Millennium Management LLC0.20%
Vanguard Capital Management, LLC0.16%
Aaron Wealth Advisors LLC0.11%
Tamar Securities, LLC0.10%
Citadel Advisors Llc0.09%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Turn Therapeutics Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.